Inspection Readiness: Before. During. After
Your organization has received a Form 482 Notice of Inspection. What now?
While they are often stressful and sometimes unforeseen, FDA inspections are intended to ensure the protection of human research subject rights, safety, and welfare as they are involved in FDA-regulated clinical studies. Understanding the expectations of the FDA during inspections can help to resolve the apprehension of an inspection and provide the landscape for a successful inspection as well as ensure effective post-inspection activities.
Leslie Paul, Director, and Anthea Dransfield, Managing Director at Advarra Quality Center of Excellence will explore strategies for preparing for an upcoming FDA inspection, what to expect during the inspection, and steps to take following inspection close.
Learning Objectives:
-
Learn successful strategies for a proactive approach to FDA Inspections
-
Gain an in-depth understanding of regulation non-compliance and post-inspection activities
-
Identify critical issues regarding subject rights, safety, and/or welfare
Presented By
Anthea Dransfield
Managing Director
Advarra Consulting – Quality Center of Excellence
Leslie Paul
Director
Advarra Consulting – Quality Center of Excellence
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
DATE: June 17, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour